Efficacy of Praziquantel for Treatment of <i>Plasmodium falciparum</i> Infection in Asymptomatic Gabonese Adults: A Double-Blind Placebo-Controlled Randomized Trial

Findings demonstrate a statistically significant antimalarial activity of PZQ; however, the observed effect is only moderate compared to current first-line antimalarial treatments. Future research should investigate the synergistic potential of combining PZQ and antimalarial drugs in malaria and schistosomiasis control. Clinical Trials Registration.Pan African Clinical Trials Registry, PACTR202206584817951, 10 June 2022 (https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=22586).

Authors

Institutions

Publication Details

Journal
The Journal of Infectious Diseases
Published
2025-10-28
DOI
https://doi.org/10.1093/infdis/jiaf544
Primary Topic
Malaria Research and Control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of Praziquantel for Treatment of Plasmodium falciparum Infection in Asymptomatic Gabonese Adults: A Double-Blind Placebo-Controlled Randomized Trial

Michael Ramharter, Rella Zoleko‐Manego, Ghyslain Mombo‐Ngoma, Michael Vögler et al.
The Journal of Infectious Diseases
Malaria Research and Control
article

Efficacy of Praziquantel for Treatment of Plasmodium falciparum Infection in Asymptomatic Gabonese Adults: A Double-Blind Placebo-Controlled Randomized Trial

Michael Ramharter, Rella Zoleko‐Manego, Ghyslain Mombo‐Ngoma, Michael Vögler, Andrea Kreidenweiss, Wilfrid Ndzebe Ndoumba, Dearie Glory Okwu, Peter G. Kremsner, Johannes Mischlinger, Florian Kurth, Anna Bachmann, Ayôla Akim Adégnika, Jacob Werner, Francisca Sarpong, Klara Pechmann, Cäcilie von Wedel, Alex Hounmenou Zinsou, Lidwine Badjina
article en

Abstract

Findings demonstrate a statistically significant antimalarial activity of PZQ; however, the observed effect is only moderate compared to current first-line antimalarial treatments. Future research should investigate the synergistic potential of combining PZQ and antimalarial drugs in malaria and schistosomiasis control. Clinical Trials Registration.Pan African Clinical Trials Registry, PACTR202206584817951, 10 June 2022 (https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=22586).

The Journal of Infectious DiseasesVol. 233(3)
Universität Hamburg (DE), Humboldt-Universität zu Berlin (DE), Universitätsklinikum Tübingen (DE), Centre de Recherche Médicales de Lambaréné (GA), University Medical Center Hamburg-Eppendorf (DE), German Center for Infection Research (DE), University of Tübingen (DE), Bernhard Nocht Institute for Tropical Medicine (DE)
Openalex Percentile: Top 59%
Malaria Research and Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.